HQL · abrdn Life Sciences Investors · Executive Compensation
Market Cap
$547.34M
Shares
30.41M
Volume · Oct 27
166.85K
Avg daily vol (3M)
137.57K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Leadership
- C. William Maher Board Member
- Jefferey Bailey Board Member
- Kathleen Goetz Board Member
- Rose DiMartino Board Member
- Stephen Bird Board Member
- Todd Reit Board Member